Recent Finacing
Recent Raise
Radiopharm Theranostics develops diagnostic and therapeutic radiopharmaceuticals and advances preclinical TROP2 nanobody and LRRC15 monoclonal antibody programs through development, manufacturing, and partner collaborations.
